Barrett’s Esophagus Patient-Reported Outcome Measure in

Overview

About this study

The purpose of this study is to develop a Barrett’s Esophagus specific PRO instrument measuring quality of life in patients with dysplastic and non-dysplastic Barrett’s esophagus (BE). We will perform a) qualitative patient interviews for item generation, concept elicitation and identify symptom domains; b) cognitive interviews to ensure content validity.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Confirmed diagnosis of Barrett’s esophagus who are either in the surveillance, active treatment, or post-treatment surveillance phases.
  • At least 18 years of age at the time of consent
  • Able and willing to provide informed consent
  • Able and willing to comply with required study procedures

Exclusion Criteria: 

  • Non-english speaking

Note: Other protocol defined Inclusion/Exclusion criteria may apply.

Eligibility last updated 9/19/23. Questions regarding updates should be directed to the study team contact

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Jacksonville, Fla.

Mayo Clinic principal investigator

Swathi Eluri, M.D.

Open for enrollment

Contact information:

Michelle McCain

(904) 953-4355

McCain.Michelle@mayo.edu

More information

Publications

Publications are currently not available
.
CLS-20566454

Mayo Clinic Footer